The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Allergy Immunotherapy Market Research Report 2024

Global Allergy Immunotherapy Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1416827

No of Pages : 86

Synopsis

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies.

It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

The global Allergy Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapy.

Report Scope

The Allergy Immunotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Allergy Immunotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • ALK-Abello
  • Stallergenes Greer
  • Merck
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti

Segment by Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

Segment by Application

  • Allergic Rhinitis
  • Allergic Asthma
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allergy Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Allergy Immunotherapy Market Overview
1.1 Product Overview and Scope of Allergy Immunotherapy
1.2 Allergy Immunotherapy Segment by Type
1.2.1 Global Allergy Immunotherapy Market Value Comparison by Type (2024-2030)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Allergy Immunotherapy Segment by Application
1.3.1 Global Allergy Immunotherapy Market Value by Application: (2024-2030)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Others
1.4 Global Allergy Immunotherapy Market Size Estimates and Forecasts
1.4.1 Global Allergy Immunotherapy Revenue 2019-2030
1.4.2 Global Allergy Immunotherapy Sales 2019-2030
1.4.3 Global Allergy Immunotherapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Allergy Immunotherapy Market Competition by Manufacturers
2.1 Global Allergy Immunotherapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Allergy Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Allergy Immunotherapy Average Price by Manufacturers (2019-2024)
2.4 Global Allergy Immunotherapy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Allergy Immunotherapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Allergy Immunotherapy, Product Type & Application
2.7 Allergy Immunotherapy Market Competitive Situation and Trends
2.7.1 Allergy Immunotherapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Allergy Immunotherapy Players Market Share by Revenue
2.7.3 Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Allergy Immunotherapy Retrospective Market Scenario by Region
3.1 Global Allergy Immunotherapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Allergy Immunotherapy Global Allergy Immunotherapy Sales by Region: 2019-2030
3.2.1 Global Allergy Immunotherapy Sales by Region: 2019-2024
3.2.2 Global Allergy Immunotherapy Sales by Region: 2025-2030
3.3 Global Allergy Immunotherapy Global Allergy Immunotherapy Revenue by Region: 2019-2030
3.3.1 Global Allergy Immunotherapy Revenue by Region: 2019-2024
3.3.2 Global Allergy Immunotherapy Revenue by Region: 2025-2030
3.4 North America Allergy Immunotherapy Market Facts & Figures by Country
3.4.1 North America Allergy Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Allergy Immunotherapy Sales by Country (2019-2030)
3.4.3 North America Allergy Immunotherapy Revenue by Country (2019-2030)
3.5 Europe Allergy Immunotherapy Market Facts & Figures by Country
3.5.1 Europe Allergy Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Allergy Immunotherapy Sales by Country (2019-2030)
3.5.3 Europe Allergy Immunotherapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Allergy Immunotherapy Market Facts & Figures by Country
3.6.1 Asia Pacific Allergy Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Allergy Immunotherapy Sales by Country (2019-2030)
3.6.3 Asia Pacific Allergy Immunotherapy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Allergy Immunotherapy Market Facts & Figures by Country
3.7.1 Latin America Allergy Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Allergy Immunotherapy Sales by Country (2019-2030)
3.7.3 Latin America Allergy Immunotherapy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Allergy Immunotherapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Allergy Immunotherapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Allergy Immunotherapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Allergy Immunotherapy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Allergy Immunotherapy Sales by Type (2019-2030)
4.1.1 Global Allergy Immunotherapy Sales by Type (2019-2024)
4.1.2 Global Allergy Immunotherapy Sales by Type (2025-2030)
4.1.3 Global Allergy Immunotherapy Sales Market Share by Type (2019-2030)
4.2 Global Allergy Immunotherapy Revenue by Type (2019-2030)
4.2.1 Global Allergy Immunotherapy Revenue by Type (2019-2024)
4.2.2 Global Allergy Immunotherapy Revenue by Type (2025-2030)
4.2.3 Global Allergy Immunotherapy Revenue Market Share by Type (2019-2030)
4.3 Global Allergy Immunotherapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Allergy Immunotherapy Sales by Application (2019-2030)
5.1.1 Global Allergy Immunotherapy Sales by Application (2019-2024)
5.1.2 Global Allergy Immunotherapy Sales by Application (2025-2030)
5.1.3 Global Allergy Immunotherapy Sales Market Share by Application (2019-2030)
5.2 Global Allergy Immunotherapy Revenue by Application (2019-2030)
5.2.1 Global Allergy Immunotherapy Revenue by Application (2019-2024)
5.2.2 Global Allergy Immunotherapy Revenue by Application (2025-2030)
5.2.3 Global Allergy Immunotherapy Revenue Market Share by Application (2019-2030)
5.3 Global Allergy Immunotherapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ALK-Abello
6.1.1 ALK-Abello Corporation Information
6.1.2 ALK-Abello Description and Business Overview
6.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio
6.1.5 ALK-Abello Recent Developments/Updates
6.2 Stallergenes Greer
6.2.1 Stallergenes Greer Corporation Information
6.2.2 Stallergenes Greer Description and Business Overview
6.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio
6.2.5 Stallergenes Greer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Allergy Immunotherapy Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Allergy Therapeutics
6.4.1 Allergy Therapeutics Corporation Information
6.4.2 Allergy Therapeutics Description and Business Overview
6.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio
6.4.5 Allergy Therapeutics Recent Developments/Updates
6.5 HAL
6.5.1 HAL Corporation Information
6.5.2 HAL Description and Business Overview
6.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HAL Allergy Immunotherapy Product Portfolio
6.5.5 HAL Recent Developments/Updates
6.6 Holister Stier
6.6.1 Holister Stier Corporation Information
6.6.2 Holister Stier Description and Business Overview
6.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Holister Stier Allergy Immunotherapy Product Portfolio
6.6.5 Holister Stier Recent Developments/Updates
6.7 Leti
6.6.1 Leti Corporation Information
6.6.2 Leti Description and Business Overview
6.6.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Leti Allergy Immunotherapy Product Portfolio
6.7.5 Leti Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Allergy Immunotherapy Industry Chain Analysis
7.2 Allergy Immunotherapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Allergy Immunotherapy Production Mode & Process
7.4 Allergy Immunotherapy Sales and Marketing
7.4.1 Allergy Immunotherapy Sales Channels
7.4.2 Allergy Immunotherapy Distributors
7.5 Allergy Immunotherapy Customers
8 Allergy Immunotherapy Market Dynamics
8.1 Allergy Immunotherapy Industry Trends
8.2 Allergy Immunotherapy Market Drivers
8.3 Allergy Immunotherapy Market Challenges
8.4 Allergy Immunotherapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’